Systemic Therapy for Advanced Hepatocellular Carcinoma

Patient Guideline

Publication Date: March 18, 2024
Last Updated: May 14, 2024

 

 

This patient guideline summarizes key takeaways from the American Society of Clinical Oncology (ASCO) guidelines for Systemic Therapy for Advanced Hepatocellular Carcinoma (HCC). The purpose of this guidance is to provide new evidence-based recommendations to support clinical decision-making for patients with advanced HCC.